Area of research
Cancer Research · Genetics
Research interest
Research interests include MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Genetics and Neurodevelopmental Disorders, and Epigenetics and DNA Methylation.
Non-Invasive Detection of Tumors by Volatile Organic Compounds in Urine.
In Vivo Engineered CAR-T Cell Therapy: Lessons Built from COVID-19 mRNA Vaccines.
Storage Time and DNA Quality Determine BRCA1/2 Sequencing Success in Prostate Cancer: A Multicentre Analysis with Therapeutic Implications
Storage Time and DNA Quality Determine <i>BRCA1/2</i> Sequencing Success in Prostate Cancer: A Multicentre Analysis with Therapeutic Implications.
Recent Exploration of Solid Cancer Biomarkers Hidden Within Urine or Blood Exosomes That Provide Fundamental Information for Future Cancer Diagnostics.
Trends in Thyroid Fine-Needle Aspiration Cytology - Results from the Italian Cytopathology Committee National Practice Survey
miR-1297 is frequently downmodulated in flat epithelial atypia of the breast and promotes mammary neoplastic transformation via EphrinA2 regulation.
Clinicopathologic Features of Isolated AFOP Nodules Radiologically Mimicking Malignancy in Post COVID-19 Patients: A Case Series Study.
High-Throughput Molecular Characterization of the Microbiome in Breast Implant-Associated Anaplastic Large Cell Lymphoma and Peri-Implant Benign Seromas.
Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma.
Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer.
Integrating the Idylla™ System Alongside a Real-Time Polymerase Chain Reaction and Next-Generation Sequencing for Investigating Gene Fusions in Pleural Effusions from Non-Small-Cell Lung Cancer Patients: A Pilot Study.
Prognostic Factors of Non-Predominant-Lepidic Lung Adenocarcinoma Presenting as Ground Glass Opacity: Results of a Multicenter Study.
Author Correction: Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer.
Is CT Radiomics Superior to Morphological Evaluation for pN0 Characterization? A Pilot Study in Colon Cancer.
The Multifaceted Complexity of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS): A Case Report Highlighting Atypical Gastrointestinal Manifestations.
PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian survey.
Tissue fluidification promotes a cGAS-STING cytosolic DNA response in invasive breast cancer.
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis.
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma.
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance.
Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance.
Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin.
Histologic Analysis of Idiopathic Pulmonary Fibrosis by Morphometric and Fractal Analysis.
Loss of CDKN1B induces an age-related clonal hematopoietic disorder via Notch2 activity dysregulation.
Author Correction: Tissue fluidification promotes a cGAS-STING cytosolic DNA response in invasive breast cancer.
Data from Alterations of the Tumor Suppressor Gene <i>ARLTS1</i> in Ovarian Cancer
Data from Alterations of the Tumor Suppressor Gene <i>ARLTS1</i> in Ovarian Cancer
CDK4/6 Inhibitors in Combination Therapies: Better in Company Than Alone: A Mini Review.